Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Tilray
|
| gptkbp:accessories |
Local growers
|
| gptkbp:acquisition |
gptkb:2021
Aphria Inc. |
| gptkbp:awards |
Industry awards for excellence
|
| gptkbp:brand |
gptkb:Tilray
Various influencers Strong brand presence |
| gptkbp:business_model |
B2 B and B2 C
|
| gptkbp:category |
Capsules
Edibles Oils Topicals Dried flower |
| gptkbp:ceo |
gptkb:Irwin_Simon
|
| gptkbp:certification |
GMP certified
|
| gptkbp:clinical_trial |
Ongoing clinical trials
|
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:community_engagement |
Local community support programs
|
| gptkbp:community_involvement |
Educational initiatives
|
| gptkbp:customer_base |
Patients and consumers
|
| gptkbp:customer_support |
Dedicated support team
|
| gptkbp:distribution |
Multiple countries
Worldwide |
| gptkbp:distribution_channels |
Online and retail
|
| gptkbp:employees |
Over 1000
|
| gptkbp:exported_to |
Cannabis to international markets
|
| gptkbp:financial_performance |
Strong growth trajectory
|
| gptkbp:financial_products |
Venture capital firms
|
| gptkbp:founded |
gptkb:2018
|
| gptkbp:governed_by |
Darren Karasiuk
|
| gptkbp:headquarters |
gptkb:Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tilray Holdings Switzerland
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:innovation |
Cannabis-infused products
New product lines |
| gptkbp:investment |
Series A funding
Cannabis research and development |
| gptkbp:is_tested_for |
Rigorous testing protocols
|
| gptkbp:market |
Global
Consumer insights New cannabis strains Leading cannabis company |
| gptkbp:market_cap |
$3 billion (2021)
|
| gptkbp:marketing_strategy |
gptkb:Global_expansion
|
| gptkbp:parent_company |
Tilray, Inc.
|
| gptkbp:partnership |
Various pharmaceutical companies
University research collaborations |
| gptkbp:philanthropy |
gptkb:Charitable_donations
|
| gptkbp:products |
Cannabis products
Medical cannabis High-quality standards Recreational cannabis |
| gptkbp:regulatory_compliance |
gptkb:Health_Canada
Compliant with local laws |
| gptkbp:research_focus |
Cannabinoid research
|
| gptkbp:revenue |
$210 million (2021)
|
| gptkbp:social_media_presence |
Active on multiple platforms
|
| gptkbp:subsidiary |
Tilray Canada Ltd.
|
| gptkbp:supply_chain |
Efficient logistics
Vertical integration |
| gptkbp:sustainability_initiatives |
Environmental responsibility programs
Reduce carbon footprint |
| gptkbp:symbol |
gptkb:TLRY
|
| gptkbp:training |
Ongoing training programs
|
| gptkbp:website |
www.tilray.com
|